Form 4: Corbus Pharmaceuticals CFO Sells Shares to Cover Tax Obligations

Sean F. Moran, CFO of Corbus Pharmaceuticals, sold 2,792 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• Sean F. Moran, the Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc., sold 2,792 shares of the company's common stock on February 14, 2025.
• The sale was executed at a weighted average price of $8.7559 per share, with individual transactions ranging from $8.30 to $9.14.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2024.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• Following the transaction, Moran directly owns 73,313 shares, which includes 57,632 unvested RSUs.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Management Comments

• The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares by the CFO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Corbus Pharmaceuticals, Sean F. Moran, CFO, stock sale, Form 4, RSU, Rule 10b5-1, tax withholding